Earnings per share for the last twelve months: iCAD Inc. (ICAD)

Corporate company logo of iCAD Corp (ICAD)

iCAD, Inc. is implementing AI algorithms for the early detection of oncology in radiology centers. A strong team of imaging experts supports the company's mission and ensures low staff turnover. The rolling earnings per share trend demonstrates the impact of these factors, where the -0.20 mark characterizes this parameter. The transition to cloud subscriptions stabilizes revenue, despite the lengthy sales cycles associated with clinics.

ICAD (iCAD Corp) Net earnings per one share for the last twelve months history from 07/04/2022 to 08/02/2025

ICAD (iCAD Inc.): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Quotes iCAD Corp|ICAD - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value iCAD, Inc.|ICAD - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Book Value per Share iCAD|ICAD - Total Stockholders' Equity|Market Capitalization to Book Value Ratio icadmed.com|ICAD - Company Total Asset Base
- debt obligations and liquidity statistics:
Total Debt to Capital iCAD, Inc.|ICAD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital iCAD Corp|ICAD - Company Aggregate Debts|Debts to Book Capitalization iCAD, Inc.|ICAD - Company Long-Term Indebtedness|Company Current Liabilities iCAD|Quick Ratio icadmed.com
- net income and valuation multiples indicators:
ICAD - Net Financial Result|Expected Profit iCAD, Inc.|ICAD - Price to Earnings Multiple|Forward P/E Multiple iCAD Corp|ICAD - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio iCAD, Inc.|ICAD - Operating income before deduction of amortization|Net earnings per share (EPS TTM) iCAD|ICAD - Net earnings per share for the last four quarters|Quarterly EPS earnings growth icadmed.com|ICAD - Net earnings per share growth this year|Earnings growth forecast for next year iCAD, Inc.
Analysis of all company metrics:icadmed.com (ICAD)
Manufactured products of iCAD Inc.

iCAD, Inc. (ICAD) holds a leading position in the AI oncology diagnostics segment. By analyzing the annual net income per share, an investor can see the current business efficiency over the last 12 months. This metric recalculates total income per share, neutralizing the time lag of quarterly reports. Steady growth in this trend confirms the monetization of ProFound AI licenses. Such price action proves the fundamental stability of the issuer's cash flow.

Direct competitors

ONC: Net earnings per share for the last 12 months|HALO - Net earnings per share (EPS TTM)|Revolution Medicines, Inc. (RVMD) - Earnings per share for the last twelve months|Ascentage Pharma Group International - Earnings per share for the trailing year|CGON (CG Oncology Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months UroGen Pharma Corp URGN|Net earnings per share (EPS TTM) BCAX|Net earnings per share for the last four quarters personalis.com|Net earnings per share (EPS TTM) ERAS (Erasca)|DCTH - Net earnings per share for the last 12 months|YmAbs - Net earnings per share (EPS TTM)|AURA - Net earnings per share (EPS TTM)|CADL: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ARAY|Net earnings per share for the last 12 months SLS|ACTU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CTOR|Net earnings per share for the last four quarters tuhurabio.com|Earnings per share for the last twelve months Protara Therapeutics TARA|FATE: Earnings per share for the last 12 months|Aadi Bio - Net earnings per share (EPS TTM)|TScan Therapeutics (TCRX) - Net earnings per share for the last 12 months|CSBR (championsoncology.com) - Net earnings per share for the last 12 months|XBIT - Net earnings per share for the last four quarters|CVM (CEL-SCI Corp.) - Net earnings per share (EPS TTM)|ostherapies.com (OSTX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) RADX|Net earnings per share for the last 12 months artivabio.com ARTV|Net earnings per share (EPS TTM) ANL (Adlai Nortye)|Net earnings per share (EPS TTM) Veru Corporation VERU|Tempest Therapeutics - Net earnings per share (EPS TTM)|XLO (Xilio Therapeutics, Inc.) - Earnings per share for the last 12 months|RENB: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Mural Oncology|KAPA (Kairos Pharma Limited) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) OnKure|Earnings per share for the last twelve months CytoMed Therapeutics (GDTC)|curis.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) APLM (Apollomics)|THAR - Net earnings per share for the last 12 months|Advanced Biomed Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Genprex Inc|calidibio.com (CLDI) - Earnings per share for the last twelve months|Sunshine Biopharma Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months XBIO|SLRX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PPBT|Net earnings per share for the last 12 months aoncology.com AONC|BeiGene, Ltd. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) checkpointtx.com CKPT|ELEV - Earnings per share for the last twelve months|Earnings per share for the trailing year IKNA (Ikena Oncology, Inc.)|NTBL: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Viracta Therapeutics, Inc. (VIRX)|MOR (MorphoSys AG) - Net earnings per share (EPS TTM)|nayabiosciences.com (NAYA) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) AAPGV